UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Journal of Crohn's & colitis, 2010-02, Vol.4 (1), p.28-62

2010

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients

Cellular and molecular gastroenterology and hepatology, 2021-01, Vol.11 (3), p.889-891.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Can Nurses Manage Gastrointestinal Symptoms Arising from Pelvic Radiation Disease?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-10, Vol.23 (8), p.538-551

2011

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Nonadherence to Thiopurines in Adolescent and Adult Patients With Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2012-05, Vol.54 (5), p.685-689

2012

Link zum Volltext

Verfügbarkeit prüfen

Diet Low in FODMAPs Reduces Symptoms in Patients with Irritable Bowel Syndrome and Probiotic Restores Bifidobacterium Species: a Randomized Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2017-10, Vol.153 (4), p.936-947

2017

Link zum Volltext

Verfügbarkeit prüfen

Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española)

Revista de gastroenterología de México, 2015-01, Vol.80 (1), p.74-106

2015

Link zum Volltext

Verfügbarkeit prüfen

Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española)

Revista de gastroenterología de México, 2015-01, Vol.80 (1), p.32-73

2015

Link zum Volltext

Verfügbarkeit prüfen

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

Revista de gastroenterología de México, 2014-10, Vol.79 (4), p.263-289

2014

Link zum Volltext

Verfügbarkeit prüfen

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials

Proceedings of the Nutrition Society, 2007-08, Vol.66 (3), p.307-315

2007

Link zum Volltext

Verfügbarkeit prüfen

Adolescents with IBD: the importance of structured transition care

Journal of Crohn's and colitis, 2011-12, Vol.5 (6), p.509-519

2011

Link zum Volltext

Verfügbarkeit prüfen

P053 Circulating non-classical monocytes are reduced in patients with active IBD but increase after vedolizumab: a role for α4β7 in myeloid cell recruitment to the inflamed intestine

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S104-S105

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel disease in young people: The case for transitional clinics

Inflammatory bowel diseases, 2010-06, Vol.16 (6), p.947-952

2010

Link zum Volltext

Verfügbarkeit prüfen

Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease

Inflammatory bowel diseases, 2011-10, Vol.17 (10), p.2027-2037

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease

Mucosal immunology, 2017-01, Vol.10 (1), p.184-193

2017

Link zum Volltext

Verfügbarkeit prüfen

P070 TNFα production by classical monocytes is poorly controlled by IL-10 in patients with IBD

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S112-S112

2017

Link zum Volltext

Verfügbarkeit prüfen

Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial

Proceedings of the Nutrition Society, 2017, Vol.76 (OCE4), Article E157

2017

Link zum Volltext

Verfügbarkeit prüfen

Volatile organic compounds predict response to both low FODMAP diet and probiotics in irritable bowel syndrome: a randomised controlled trial

Proceedings of the Nutrition Society, 2017, Vol.76 (OCE4), Article E156

2017

Link zum Volltext

Verfügbarkeit prüfen

P614 Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S393-S393

2017

Link zum Volltext

Verfügbarkeit prüfen

P467 Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S315-S317

2017

Link zum Volltext

Verfügbarkeit prüfen

OP004 Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S2-S3

2017

Link zum Volltext

Verfügbarkeit prüfen

P558 The SF-36® Health Survey distinguishes disease burden on functioning and well-being between patients with active vs inactive ulcerative colitis

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S364-S365

2017

Link zum Volltext

Verfügbarkeit prüfen

OP020 16S rRNA gene pyrosequencing indicate that siblings of Crohn's disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S11-S12

2014

Link zum Volltext

Verfügbarkeit prüfen

P053 Interleukin-17A homodimer reduces pro-inflammatory cytokine production by inflammatory bowel disease mucosa cultured ex vivo

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S85-S85

2014

Link zum Volltext

Verfügbarkeit prüfen

P024 Ulcerative colitis versus Crohn's disease: differences observed in the IMPACT survey

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S19-S20

2013

Link zum Volltext

Verfügbarkeit prüfen

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento

Revista de gastroenterología de México, 2014-10, Vol.79 (4), p.263-289

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(48)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(14)
Female
(10)
Male
(10)
Adult
(9)
Adolescent
(7)
Gastroenterology & Hepatology
(7)
Middle Aged
(7)
Young Adult
(6)
Aged
(5)
Crohn's Disease
(5)
Animals
(4)
Child
(4)
Gastroenterology And Hepatology
(4)
Inflammatory Bowel Disease
(4)
Clinical Trials
(3)
Crohn Disease - Pathology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Intestine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients

Can Nurses Manage Gastrointestinal Symptoms Arising from Pelvic Radiation Disease?

Factors Associated With Nonadherence to Thiopurines in Adolescent and Adult Patients With Inflammatory Bowel Disease

Diet Low in FODMAPs Reduces Symptoms in Patients with Irritable Bowel Syndrome and Probiotic Restores Bifidobacterium Species: a Randomized Controlled Trial

Segundo consenso europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Parte 3: situaciones especiales (versión española)

Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española)

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials

Adolescents with IBD: the importance of structured transition care

P053 Circulating non-classical monocytes are reduced in patients with active IBD but increase after vedolizumab: a role for α4β7 in myeloid cell recruitment to the inflamed intestine

Inflammatory bowel disease in young people: The case for transitional clinics

Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease

Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease

P070 TNFα production by classical monocytes is poorly controlled by IL-10 in patients with IBD

Fermentable carbohydrates (FODMAPs) as triggers of functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial

Volatile organic compounds predict response to both low FODMAP diet and probiotics in irritable bowel syndrome: a randomised controlled trial

P614 Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis

P467 Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis

OP004 Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease

P558 The SF-36® Health Survey distinguishes disease burden on functioning and well-being between patients with active vs inactive ulcerative colitis

OP020 16S rRNA gene pyrosequencing indicate that siblings of Crohn's disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities

P053 Interleukin-17A homodimer reduces pro-inflammatory cytokine production by inflammatory bowel disease mucosa cultured ex vivo

P024 Ulcerative colitis versus Crohn's disease: differences observed in the IMPACT survey

Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento

Suchergebnisse filtern